{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amoxicillin%2FClavulanate", "query": { "intervention": "Amoxicillin/Clavulanate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 76, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amoxicillin%2FClavulanate&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-15T22:52:54.493Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02891915", "title": "Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Cefdinir", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "6 Months to 71 Months" }, "enrollment_count": 385, "start_date": "2016-12-02", "completion_date": "2019-12-16", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Louisville, Kentucky + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02891915" }, { "nct_id": "NCT01530763", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections", "Community Acquired Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "amoxicillin clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Months to 18 Years" }, "enrollment_count": 161, "start_date": "2012-09", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 13, "location_summary": "Long Beach, California • Oakland, California • Orange, California + 10 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01530763" }, { "nct_id": "NCT05519072", "title": "Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Antibiotic Prophylaxis" ], "interventions": [ { "name": "Nitrofurantoin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Atlantic Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 140, "start_date": "2022-08-16", "completion_date": "2024-08-16", "has_results": false, "last_update_posted_date": "2024-03-27", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 1, "location_summary": "Morristown, New Jersey", "locations": [ { "city": "Morristown", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05519072" }, { "nct_id": "NCT03818815", "title": "A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "OP0201", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "Novus Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "6 Months to 24 Months" }, "enrollment_count": 103, "start_date": "2019-02-21", "completion_date": "2020-03-26", "has_results": true, "last_update_posted_date": "2020-08-18", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03818815" }, { "nct_id": "NCT03755765", "title": "Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Antibiotic-associated Diarrhea" ], "interventions": [ { "name": "Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet", "type": "DRUG" }, { "name": "BB-12", "type": "BIOLOGICAL" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 66, "start_date": "2019-07-23", "completion_date": "2020-01-08", "has_results": true, "last_update_posted_date": "2023-02-17", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03755765" }, { "nct_id": "NCT03358576", "title": "Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Intra Abdominal Infections" ], "interventions": [ { "name": "Ertapenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate", "type": "DRUG" }, { "name": "Sulopenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 674, "start_date": "2018-09-18", "completion_date": "2019-10-02", "has_results": true, "last_update_posted_date": "2020-12-01", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 12, "location_summary": "Chula Vista, California • Torrance, California • Idaho Falls, Idaho + 8 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03358576" }, { "nct_id": "NCT00643292", "title": "A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "amoxicillin/clavulanate postassium (Augmentin ES-600)", "type": "DRUG" }, { "name": "azithromycin SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "48 Months", "sex": "ALL", "summary": "3 Months to 48 Months" }, "enrollment_count": 902, "start_date": "2003-01", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2011-05-17", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 23, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Bellflower, California + 18 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643292" }, { "nct_id": "NCT06277609", "title": "A Trial Investigating Lu AF28996 in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Lu AF28996", "type": "DRUG" }, { "name": "Acetylsalicylic Acid", "type": "DRUG" }, { "name": "Mefenamic Acid", "type": "DRUG" }, { "name": "Amoxicillin/clavulanic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 22, "start_date": "2024-02-27", "completion_date": "2024-05-19", "has_results": false, "last_update_posted_date": "2024-06-11", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06277609" }, { "nct_id": "NCT00368537", "title": "Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Skin Diseases, Bacterial" ], "interventions": [ { "name": "Tigecycline", "type": "DRUG" }, { "name": "ampicillin-sulbactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2006-09", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 31, "location_summary": "Scottsdale, Arizona • Jonesboro, Arkansas • Chula Vista, California + 27 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00368537" }, { "nct_id": "NCT05846399", "title": "CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cat Bite", "Hand Injuries", "Arm Injury", "Infection, Bacterial", "Anti-bacterial Agents" ], "interventions": [ { "name": "Amoxicillin/clavulanate", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Placebo (microcrystalline cellulose)", "type": "OTHER" }, { "name": "Wound management", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2023-09-07", "completion_date": "2027-08-01", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-09-15T22:52:54.493Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846399" } ] }